MCR American Pharmaceuticals is a specialty pharmaceutical company that focuses on the marketing, development, sales and distribution of the highest quality pharmaceuticals, recently the company released a new group of medications that aims to relieve the common cold.

Brooksville, Florida — June 25, 2012

Specialty pharmaceutical company MCR American Pharmaceuticals recently announced its new product line of cold fighting medications, Super-Tuss PE and Super-Tuss PSE.

Super-Tuss PE is a suppressant, expectorant, decongestant and antihistamine. MCR American Pharmaceuticals explains that Super-Tuss PE comes in an AM dose form and a PM dose form. The AM dose is a cough suppressant, expectorant and nasal decongestant combination that contains Dextromethorphan, Guaifenesin, and Phenylephrine. The PM dose is a antihistamine and cough suppressant combination that contains Chlorpheniramine and Dextromethorphan. Both dose forms are ideal in fighting the common cold, sinusitis, hay fever, and allergic rhinitis. Super-Tuss PE is suitable for ages two and older.

There are hundreds of cold fighting medications out in the market, yet many of them are suitable for older ages, however, MCR American Pharmaceuticals manufactured Super-Tuss PE to contain low doses of Chlorpheniramine, Dextromethorphan, Guaifenesin, Phenylephrine, and Chlorpheniramine to ensure the medication is suitable for younger ages and is safe to use by a wider audience of cold-afflicted patients.

Super-Tuss PSE also arrives in an AM and PM dose form. The AM dose is a cough suppressant, expectorant, and decongestant combination that contains Dextromethorphan, Guaifenesin, and Pseudoephedrine. The PM dose is a antihistamine and cough suppressant combination that contains Chlorpheniramine and Dextromethorphan. Both dose forms are ideal in fighting the common cold, sinusitis, hay fever, and allergic rhinitis.

Most pharmaceutical companies charge hefty prices for their products and offer little personal service, however, MCR American Pharmaceuticals recently restructured its company and cut its middleman, therefore the company caters directly to consumers and medical professionals. By losing the middleman, MCR American Pharmaceuticals ensure its customers receive affordable medications and better service. Customers can now purchase their medications on the company's Web site.

MCR American Pharmaceuticals explained the company decided to remove its middleman and cater directly to its customers because such an approach can be an effective strategy for end users to save money and receive direct care. Rather than sell its products through a warehouse and charge more money, MCR American Pharmaceuticals sells its medication products on the company's Web site so medical professionals and customers can directly place their order without paying an additional fee to offset the costs of the middleman.

In conclusion, MCR American Pharmaceuticals manufactured cold-fighting medications called Super-Tuss PE and Super-Tuss PSE. Both products are decongestants and expectorants that arrive in an AM and PM form and are recommended in fighting the common cold, sinusitis, hay fever, and allergic rhinitis.

More About MCR American Pharmaceuticals

Brooksville-based Specialty pharmaceutical company, MCR American Pharmaceuticals, was founded in 1991 by Jack Reagin. MCR American Pharmaceuticals quickly expanded to several states in the Southeast. In 1999, MCR American Pharmaceuticals was purchased by David Ambrose. MCR American Pharmaceuticals is a specialty pharmaceutical company that focuses on the marketing, development, sales and distribution of the highest quality pharmaceuticals. MCR American Pharmaceuticals sells Maxiphen, Maxifed, Congestinex and Super-Tuss products. All medications are available for purchase on the MCR American Pharmaceuticals company Web site.

For additional information, interview and image request contact Virtuos Online.